共 50 条
[41]
Baseline [123I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease
[J].
ACTA NEUROLOGICA SCANDINAVICA,
2014, 129 (03)
:204-208
[42]
The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism
[J].
European Journal of Nuclear Medicine and Molecular Imaging,
2008, 35
:1367-1376
[47]
Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT
[J].
European Journal of Nuclear Medicine and Molecular Imaging,
2005, 32
:308-313
[50]
SPECT Studies with the 123I-labeled Dopamine Transporter Ligands FP-CIT (DaTSCANTM) DGN Recommendation for Action (S1 Guideline)
[J].
NUKLEARMEDIZIN-NUCLEAR MEDICINE,
2019, 58 (01)
:5-14